Shen et al. have shown that EVs derived from chemotherapy-treated breast cancer cells induced a cancer stem-like cell phenotype and conferred cancer cells with resistance to therapy, which arose from the downregulation of the transcription factor One Cut homeobox 2 (ONECUT2) and an increase in ABC transporters [93]. The gene discussed is ONECUT2; the disease is cancer.